Logos Global Management LP - Q3 2018 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2018
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CYTOKINETICS INC14Q3 202312.6%
KARUNA THERAPEUTICS INC14Q3 20235.6%
ALX ONCOLOGY HLDGS INC13Q3 202323.3%
DYNE THERAPEUTICS INC13Q3 20234.9%
APELLIS PHARMACEUTICALS INC12Q3 202312.4%
OLEMA PHARMACEUTICALS INC12Q3 202315.4%
DESIGN THERAPEUTICS INC11Q3 20238.0%
NUVATION BIO INC11Q3 20230.0%
BICYCLE THERAPEUTICS PLC10Q2 20235.7%
IDEAYA BIOSCIENCES INC9Q3 20239.5%

View Logos Global Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Logos Global Management LP Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Aeglea BioTherapeutics, Inc.July 18, 20236,350,0008.1%
BICYCLE THERAPEUTICS plcFebruary 14, 20231,435,0004.8%
Dyne Therapeutics, Inc.February 14, 20232,150,0004.1%
Design Therapeutics, Inc.March 31, 20222,797,5015.0%
IDEAYA Biosciences, Inc.March 18, 20222,650,0006.9%
Aligos Therapeutics, Inc.February 14, 2022? ?
Cogent Biosciences, Inc.February 14, 2022150,0000.4%
Kezar Life Sciences, Inc.February 14, 20221,450,0003.0%
Nkarta, Inc.February 14, 2022? ?
Viridian Therapeutics, Inc.\DEFebruary 14, 2022? ?

View Logos Global Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-01
SC 13G2024-02-22
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G2024-01-22
SC 13G2024-01-22
SC 13G2024-01-02

View Logos Global Management LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Logos Global Management LP's holdings

CSVXLS